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Abstract
Background: Cronkhite-Canada Syndrome (CCS) is a rare non-inherited disease characterized by gastrointestinal
polyposis and ectodermal abnormalities, the estimated incidence is about one per million. Recognizing and curing
the disorder face great challenge.
Case presentation: This report refers to a Chinese 52 year old man with gastrointestinal symptoms and
ectodermal abnormalities. Gastrointestinal symptoms occurred without obvious cause, followed by ectodermal
abnormalities after two months. In several hospitals, endoscopy examinations found numerous polypoid lesions in
various sizes spreading over the stomach and the entire colon and rectum, histopathological examinations showed
inflammatory and adenomatous polyp. In our hospital, both endoscopy and the contrast-enhanced computed
tomography (CT) of small intestine showed gastrointestinal polyposis. Gastric antrum and the colon biopsy samples
suggested hyperplastic and inflammatory polyp respectively. Endoscopic ultrasonography (EUS) suggested gastric
wall thickening. Fujinnon intelligent color enhancement (FICE) revealed that the size of gastric glands pit varied,
and vessels were visible. Confocal endoscope showed increased glandular epithelium layers. Magnifying narrow-band
imaging endoscopy (ME-NBI) detected that pit pattern in the mucous of the polyp were regular and type III-IV of
microvessels were seen. Biochemical investigations showed anemia, hypoalbuminemia and electrolyte disturbance.
IgG, IgA and C3 decreased. Anti-ribosomal phosphoprotein is weak positive. The patient was given nutritional support
treatment. Gstrointestinal symptoms and hyperpigmentation improved gradually.
Conclusion: The patient was ever hospitalized in four hospitals and was diagnosed with CCS after 8 months of
gastrointestinal symptoms. So when encountering the patient with gastrointestinal polyposis and ectodermal
abnormalities, try to take CCS into consideration. Due to its low incidence, no standard therapy regimen has been
established so far. However, nutritional support treatment is of great significance.
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Background
CCS is a rare non-inherited disease characterized by
gastrointestinal polyposis and ectodermal abnormalities
including hyperpigmentation, alopecia and onychody-
strophy [1]. The diagnosis of CCS is based on history,
physical examination, endoscopic findings of gastrointes-
tinal polyposis and histopathology [2]. The etiology is
not clear so far. The standard therapy regimen has not
been established. Current medical therapies include vari-
ous antibiotics, anabolic steroids, dietary supplementation,
ranitidine, glucocorticoid, immunomodulatory agent, sala-
zosulfapyridine, anti-tumor necrosis factor antibody and
anti- Helicobacter pylori regimen [3–7], surgery is neces-
sary when complications occur [8]. Its incidence is low
whereas mortality is high.
Case presentation
A 52-year-old Chinese man was admitted to our hospital
with 8-month history of diarrhea (4-5 loose stools ac-
tions per day, sometimes up to more than ten times),
bloody stools, abdominal distension, nausea, vomiting,
appetite loss and weight loss of 10 kg in the recent 8
months. Two months after the onset of gastrointestinal
symptoms, skin hyperpigmentation, fragile nails and
scalp hair loss occurred. In other hospitals, endoscopy
examinations suggested numerous polypoid lesions in
various sizes spreading over the stomach and the entire
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colon and rectum, repeated histopathological examina-
tions showed inflammatory and adenomatous polyp. The
patient was once considered to be lymphoma whereas
was not diagnosed definitely, antibiotics and symptom-
atic treatments were applied, the gastrointestinal symp-
toms did not alleviated. The patient’s occupation was
farmer and past history was unremarkable. There was
no family history of gastrointestinal polyposis. Physical
examination exhibited alopecia, atrophic nail changes,
diffuse hyperpigmentation of the skin (Fig. 1). There
were no positive findings on heart, lung, abdomen and
limbs.
Biochemical investigations detected several abnormal-
ities: a peripheral blood hemoglobin level of 115g/l (normal
range 130-175g/l), a serum total protein level of 30.6 g/l
(normal range 64–83 g/l) and a serum albumin level of
9.4g/l (normal range 20-30 g/dl). The level of serum so-
dium, potassium, chloride and calcium decreased. IgG, IgA
and C3 decreased. Anti-ribosomal phosphoprotein is weak
positive. Bacterial culture of stool found no salmonella, shi-
gella and fungus. Cortisol secretion rhythm, CRP, ESR and
IgG4 were on normal level. Upper gastrointestinal endos-
copy found diffuse polyps throughout the stomach (Fig. 2a),
EUS suggested gastric wall thickening (Fig. 2b). FICE re-
vealed that the size of the gastric glands pit varied, and ves-
sels were visible (Fig. 3a). Confocal endoscope showed
increased glandular epithelium layers (Fig. 3b). Colonos-
copy found diffuse polyps in the entire colon and rectum
(Fig. 4a). ME-NBI detected that pit pattern of glandular
tubes in the mucous of the polyp were regular and type
III-IV of microvessels were seen (Fig. 4b). Gastric antrum
and the colon biopsy samples suggested hyperplastic and
inflammatory polyp respectively (Fig. 5). The contrast-
enhanced computed tomography (CT) of small intestine
displayed widespread nodular bumps over distalileum and
entire colon (Fig. 6). Given the diffuse polyps in gastroin-
testine, the patient tended to be diagnosed with polyposis.
Further, combining polyposis with ectodermal abnormal-
ities, onset age and family history, the final diagnosis of
CCS was made. The patient was given nutritional support
treatment including fat emulsion and amino acid for two
weeks, diarrhea relieved and hyperpigmentation improved.
Then the patient discharged from the hospital, and took
proton pump inhibitor orally. But the patient didn’t re-
spond to treatment, severe diarrhea appeared again. Unfor-
tunately the patient was died three months later.
Fig. 1 Physical findings of the CCS patient. Hyperpigmentation (a), onychodystrophy (a) and alopecia (b) were seen on the patient
Fig. 2 Endoscopy findings in the stomach. Multiple polyps were seen in the stomach via gastric endoscopy (a). EUS showed gastric wall
thickening (b)
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Discussion
CCS was first described by Cronkhite and Canada in
1955 [9]. CCS can develop in all ethnic groups, but the
most frequently affected populations were European
or Asian descent and most of the cases were re-
ported from Japan [10]. The onset age was mainly
between 50 and 70 years old [2]. A slight male pre-
dominance was noted [10], the ratio of male to female
was about 1.3 ~ 2.3:1 [2].
The etiology of CCS remains unclear. Patients with
CCS accompanied by vitiligo, systemic lupus erythema-
tosus, scleroderma, hypothyroidism and membranous
glomerulonephritis have been reported in the literature
[8, 11–13], as well as CCS has been seen in association
with antinuclear antibodies, which provide evidences to
support CCS to be immune-mediated [11]. Histologic
findings of increased autoimmune-related IgG4 antibody
in CCS polyps and treatment responses to immunosup-
pressants are also consistent with an autoimmune mech-
anism underlying CCS [8]. Eric ward reported that mast
cells were seen on histopathologic analysis of intestinal
biopsies and a combination regimen containing H2-
receptorantagonists, cromolyn sodium and loratadine
was effective, which indicates the possible role of mast
cell dysfunction in the pathogenesis of CCS [3]. Goto et
al reported that stresses, such as excessive physical exer-
tion and mental strain, may trigger this syndrome. He
also reported a frequency (3%) of concurrent psychiatric
disorders in patients with CCS [14]. Mental stress may
cause local inflammation in the gastrointestinal mucosa
[11]. CCS is characterized by gastrointestinal polyposis
and ectodermal abnormalities. The polyps are character-
istically distributed throughout the entire gastrointes-
tinal tract except esophagus [1]. The histopathologic
types of the polyps have recently been reported as in-
flammatory, non-neoplastic, or retention polyps [15].
However, gastrointestinal malignancies can be as high as
15% [1]. The neoplasms develop primarily in the colon
and less frequently in the stomach [4]. Whether malig-
nant lesions arise from preexisting polyps or coinciden-
tally are a doubt. A study showed that serrated adenoma
of the polypoid lesions was retrospectively found in 10
(40%) out of 25 CCS cases with colon cancer [15]. Ser-
rated adenoma have potential to be malignant and is
Fig. 3 The changes of gastric glands, vessels, glandular epithelium in the stomach mucosa. FICE revealed that the size of gastric glands pit varied,
and vessels were visible (a). Confocal endoscope showed increased glandular epithelium layers (b)
Fig. 4 Endoscopic findings in the colon. Multiple polyps was seen in the colon via colonoscopy (a). ME-NBI detected the regular pit pattern of
glandular tubes and type III-IV of microvessels in the mucous of the polyp (b)
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often difficult to detect by endoscopy [16]. Moreover,
both serrated adenoma and hyperplastic polyps are of
sessile type and possess saw-toothed, elongated, and di-
lated crypts. However the latter does not show signifi-
cant nuclearatypia in histopathological examinations, so
serrated adenoma may be considered to be hyperplastic
polyps by mistake. It suggests that CCS associated with
colorectal cancer may frequently have polyps containing
serrated adenoma lesions [15]. Ectodermal changes may
be secondary to malabsorption [11]. In the case we re-
port, ectodermal changes occurred 2 months after the
onset of gastrointestinal symptoms. With the improve-
ment of diarrhea, hyperpigmentation relieved. However,
there are a few reports in which ectodermal changes
preceded the gastrointestinal manifestations.
Medical treatment regimens reported in the literature
vary. Corticosteroid, anabolic steroids, various antibi-
otics, dietary supplementation, ranitidine, and symptom-
atic treatment have all been used. Patients commonly
have only temporary symptomatic improvement [3]. It is
reported that steroid-resistant CCS was successfully
treated by cyclosporine and azathioprine [5], and a case
was successfully treated by anti-tumor necrosis factor
antibody after poor therapeutic effect of corticosteroids,
antiplasmin agents, and azathioprine [6]. A CCS patient
associated with HP infection achieved remission after
treatment with anti- Helicobacter pylori regimen [7].
SASP was effective in eradication of the inflammatory
polyposis [4]. Surgery may be indicated for the treatment
of bowel complications, such as severe protein-losing
enteropathy, persistent haematochezia, malignant trans-
formation [1, 8, 17] and rarely for removing the polyps
burden [8]. The progressive course of CCS makes the
mortality up to 55% [3], frequently due to complications
such as anemia, gastrointestinal bleeding, congestive
heart failure, and septicemia [5]. Therefore, it is import-
ant to be diagnosed early to provide appropriate treat-
ment and follow up. The treatment outcome in case
report is encouraging, but it has been not confirmed by
mass of evidence-based medicine.
Conclusion
CCS is a rare disease, physician should have a profound
understanding of the characteristics of gastrointestinal
polyposis including heredity factor, onset age, parenteral
manifestation and histopathology to try to avoid missed
diagnosis and misdiagnosis. In the aspect of treatment,
nutritional support treatment is fundamental, more cases
would be needed to get the optimal therapy regiment.
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